Sanford J. Siegel, M.D.

M.D., Chief Executive Officer

Sanford J. Siegel, M.D., currently serves as the Chief Executive Officer of United Urology Group, having previously been named Chairman of United Urology Group in 2020 after serving as the organization’s founding President and Chief Executive Officer in 2016 and Chief Executive Officer of Chesapeake Urology Associates, LLC, from 2006 to 2016. In his previous role as CEO of Chesapeake Urology, Dr. Siegel built the company into one of the country’s most prominent urology practices and the largest in the Mid-Atlantic Region. Dr. Siegel had been in private practice, primarily in the Baltimore area, since 1983. He earned his medical degree from the University of Maryland School of Medicine and completed his specialty training in urology at Temple University Hospital in Philadelphia.

Dr. Siegel is a recognized leader in the Baltimore and Maryland communities. He has received honors from the State of Maryland including a Governor’s Citation for outstanding commitment to the prevention and treatment of prostate cancer and two official citations from the Maryland General Assembly in recognition of his dedication to prostate cancer research and treatment, and for outstanding leadership and significant contributions in the field of medicine. The City of Baltimore also recognized Dr. Siegel for his outstanding leadership and significant contributions to the field of medicine, his dedication to improving the health of minorities, and for his commitment to the betterment of the community. The Baltimore Sun Media Group awarded Dr. Siegel with its Top Leadership award in 2015.

Dr. Siegel is a member of the American Urological Association’s Urology Care Foundation Board of Directors. He is a founding member of the Large Urology Group Practice Association (LUGPA) and served as a member of its Board of Directors and chair of both the Government Affairs and Advocacy committees from 2008 through October 2014. Dr. Siegel previously served on the board of directors for ZERO-The End of Prostate Cancer and currently is a board member of the Park Heights Community Health Alliance (PHCHA).